Status:
COMPLETED
Trial on Treatment With Inhaled Furosemide of Preterm and Term Neonates With Transient Tachypnoea
Lead Sponsor:
University of Cologne
Conditions:
Transient Tachypnoea of the Newborn
Eligibility:
All Genders
6+ years
Phase:
PHASE2
Brief Summary
In this study we will prospectively analyze the benefit of inhaled furosemide for preterm and term neonates with Transient Tachypnoea.
Detailed Description
In this study we will prospectively analyze the benefit of inhaled furosemide for preterm and term neonates with transient Tachypnoea. Patients received nebulised Furosemide iv solution 1 mg/kg or neb...
Eligibility Criteria
Inclusion
- Neonates with 35+0-39+0 GA on the first day of life with the clinical diagnosis of Transient Tachypnoea
- The need for CPAP \>6 h to obtain the oxygen saturation \>92%
- Written informed consent of parent/guardian
Exclusion
- Systemic infection
- Intubation and mechanical ventilation before Inclusion in the trail
- Malformation and any other several disease with disturb of respiratory
- Subjects participating in other clinical trials
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2015
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01407848
Start Date
January 1 2012
End Date
July 1 2015
Last Update
September 23 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children´s Hospital University of Cologne
Cologne, North Rhine-Westphalia, Germany, 50931